Barclays PLC increased its holdings in Adient plc (NYSE:ADNT - Free Report) by 127.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 208,239 shares of the company's stock after acquiring an additional 116,518 shares during the period. Barclays PLC owned approximately 0.24% of Adient worth $4,701,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Hotchkis & Wiley Capital Management LLC raised its holdings in shares of Adient by 9.3% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 5,197,090 shares of the company's stock valued at $117,298,000 after buying an additional 442,200 shares during the last quarter. Pacer Advisors Inc. increased its stake in Adient by 38,074.9% during the third quarter. Pacer Advisors Inc. now owns 5,144,445 shares of the company's stock worth $116,110,000 after acquiring an additional 5,130,969 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Adient by 1.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,078,070 shares of the company's stock valued at $125,480,000 after acquiring an additional 61,342 shares during the period. State Street Corp lifted its position in Adient by 4.8% during the 3rd quarter. State Street Corp now owns 3,443,471 shares of the company's stock worth $77,719,000 after acquiring an additional 158,017 shares in the last quarter. Finally, Pzena Investment Management LLC increased its position in shares of Adient by 45.0% during the third quarter. Pzena Investment Management LLC now owns 2,825,491 shares of the company's stock worth $63,771,000 after acquiring an additional 877,142 shares during the last quarter. Hedge funds and other institutional investors own 92.44% of the company's stock.
Adient Price Performance
ADNT stock traded down $0.41 during mid-day trading on Friday, hitting $16.85. The stock had a trading volume of 2,712,413 shares, compared to its average volume of 1,230,568. Adient plc has a 52 week low of $16.77 and a 52 week high of $37.19. The firm has a market capitalization of $1.43 billion, a P/E ratio of 73.26, a P/E/G ratio of 0.32 and a beta of 2.15. The company has a current ratio of 1.11, a quick ratio of 0.90 and a debt-to-equity ratio of 0.98. The firm has a fifty day simple moving average of $19.94 and a 200 day simple moving average of $22.16.
Adient (NYSE:ADNT - Get Free Report) last posted its earnings results on Friday, November 8th. The company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.56 by $0.12. Adient had a net margin of 0.12% and a return on equity of 6.86%. The business had revenue of $3.56 billion for the quarter, compared to the consensus estimate of $3.47 billion. During the same period last year, the company earned $0.51 EPS. The firm's revenue was down 3.7% compared to the same quarter last year. As a group, research analysts forecast that Adient plc will post 2.04 EPS for the current year.
Insider Activity
In other news, EVP James Conklin sold 11,500 shares of the stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total transaction of $232,875.00. Following the completion of the transaction, the executive vice president now directly owns 51,829 shares of the company's stock, valued at $1,049,537.25. This represents a 18.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.30% of the company's stock.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on ADNT. Wells Fargo & Company downgraded shares of Adient from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $27.00 to $20.00 in a research report on Monday, December 16th. Wolfe Research assumed coverage on shares of Adient in a research report on Thursday, September 5th. They set a "peer perform" rating on the stock. Bank of America cut Adient from a "buy" rating to a "neutral" rating and decreased their target price for the company from $30.00 to $24.00 in a research note on Thursday, November 21st. Morgan Stanley decreased their price target on shares of Adient from $21.00 to $19.00 and set an "underweight" rating on the stock in a research report on Thursday, November 14th. Finally, StockNews.com downgraded Adient from a "buy" rating to a "hold" rating in a report on Friday. One research analyst has rated the stock with a sell rating and nine have issued a hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $23.50.
Check Out Our Latest Stock Analysis on Adient
Adient Profile
(
Free Report)
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Recommended Stories
Before you consider Adient, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Adient wasn't on the list.
While Adient currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
